Completed NA INTERVENTIONAL 2-arm NCT01911078

Renal Sympathetic Denervation in Metabolic Syndrome (Metabolic Syndrome Study)

Sponsor: Abbott Medical Devices

Interventions EnligHTN™ Renal Denervation System. Renal Denervation

Updated 7 times since 2017 Last updated: Jan 31, 2019 Started: Sep 30, 2014 Primary completion: Dec 31, 2015 Completion: Jun 30, 2016

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Metabolic Syndrome and is currently completed. Abbott Medical Devices leads this study, which shows 7 recorded versions since 2014 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

7 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Mar 2019 — Jan 2021 [monthly]

Completed NA
Feb 2019 — Mar 2019 [monthly]

Completed NA

▶ Show 2 earlier versions

Jun 2018 — Feb 2019 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Sep 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Abbott Medical Devices

Data source: Abbott Medical Devices

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Athens, Greece